Abstract
Before outlining those aspects of genetic screening that may confront established and accepted modes of medical behavior as well as actual laws, it is important to review genetic screening as it is currently practiced and as it has arisen. This discussion will be confined to that screening for genetic disorders conducted routinely either on a specific age group (such as newborns) within an entire population or on a certain ethnic segment of a population. In fact, it is this type of “wholesale” testing that is usually considered to be genetic screening rather than the original type of selective testing for genetic disorders that is confined to small groups of individuals, such as those in schools for the mentally retarded or those who are admitted to hospitals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Guthrie, R. and Susi, A., A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, Pediatrics 32: 338 (1963).
Levy, H.L., Genetic screening, in “Advances in Human Genetics” (Harris, H. and Hirschhorn, K., eds.), Vol. 4, pp. 1–104, 389–394, Plenum Press, New York (1973).
Smith, I. and Wolff, O.H., Natural history of phenylketonuria and influence of early treatment, Lancet 2: 540 (1974).
Guthrie, R., Mass screening for genetic disease, Hospital Practice, June 1972, pp. 93–100.
Efron, M.L., Young, D., Moser, H.W. et al, A simple chromatographic screening test for the detection of disorders of amino acid metabolism, New Eng. J. Med. 270: 1378 (1964).
Levy, H.L., Shih, V.E., Madigan, P.M. et al, Results of a screening method for free amino acids. I. Whole blood, II. Urine, Clin. Biochem. 1: 200, 208 (1968).
Beutler, E. and Blauda, M.C., A simple spot screening test for galactosemia, J. Lab. Clin. Med. 68: 137 (1966).
Beutler, E., A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency, Blood 28: 553 (1966).
Murphey, W.H., Patchen, L. and Guthrie, R., Screening tests for argininosuccinic aciduria, orotic aciduria, and other inherited enzyme deficiencies using dried blood specimens, Biochem. Genet. 6: 51 (1972).
Garrick, M.D., Dembure, P., and Guthrie, R., Sickle-cell anemia and other hemoglobinopathies, New Eng. J. Med. 288: 1265 (1973).
Kaback, M.M. and Zeiger, R.S., Heterozygote detection in Tay-Sachs disease: a prototype community screening program in the prevention of recessive genetic disorders in “Sphingolipids, Sphingolipidoses and Allied Disorders”(Volk, B.W. and Aronson, S.M., Eds.), p. 613, Plenum Press, New York (1972).
United States Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration (Maternal and Child Health Service). State Laws Pertaining to Phenylketonuria as of November 1970, U.S. Government Printing Office, Washington (1971).
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1976 Plenum Press, New York
About this chapter
Cite this chapter
Levy, H.L. (1976). Problems in Genetic Screening which Confront the Law. In: Milunsky, A., Annas, G.J. (eds) Genetics and the Law. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2229-0_13
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2229-0_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2231-3
Online ISBN: 978-1-4684-2229-0
eBook Packages: Springer Book Archive